Key result
LAVI-derived LA diameter maintains 5-year SCD risk classification in ~95% of patients.
Why the study?
Practice guidelines for sudden cardiac death risk in hypertrophic cardiomyopathy require left atrial diameter, but echocardiography guidelines recommend left atrial volume index for size quantification.
Does estimated LA diameter derived from LAVI reclassify HCM-SCD risk compared to measured LA diameter in patients with hypertrophic cardiomyopathy?
Cross-Sectional (n=500)
Does estimated LA diameter derived from LAVI reclassify HCM-SCD risk compared to measured LA diameter in patients with hypertrophic cardiomyopathy?
Substitution of measured LA diameter by estimated LA diameter derived from LAVI in the HCM-SCD calculator does not significantly reclassify sudden cardiac death risk, allowing for the use of guideline-recommended LAVI measurements.
Supports LAVI-derived LA diameter in HCM-SCD assessment; hypothesis-generating pending prospective validation.
BACKGROUND: A subset of patients with hypertrophic cardiomyopathy (HCM) is at high risk of sudden cardiac death (SCD). Practice guidelines endorse use of a risk calculator, which requires entry of left atrial (LA) diameter. However, American Society of Echocardiography (ASE) guidelines recommend the use of LA volume index (LAVI) for routine quantification of LA size. The aims of this study were to (a) develop a model to estimate LA diameter from LAVI and (b) evaluate whether substitution of measured LA diameter by estimated LA diameter derived from LAVI reclassifies HCM-SCD risk. METHODS: The study cohort was comprised of 500 randomly selected HCM patients who underwent transthoracic echocardiography (TTE). LA diameter and LAVI were measured offline using digital clips from TTE. Linear regression models were developed to estimate LA diameter from LAVI. A European Society of Cardiology endorsed equation estimated SCD risk, which was measured using LA diameter and estimated LA diameter derived from LAVI. The derived LA diameter was 45.1 mm (SD: 5.5 mm), similar to the measured LA diameter (45.1 mm, SD: 7.1 mm). Median SCD risk at 5 years estimated by measured LA diameter was 2.22% (interquartile range (IQR): 1.39, 3.56), while median risk calculated by estimated LA diameter was 2.18% (IQR: 1.44, 3.52). 476/500 (95%) patients maintained the same risk classification regardless of whether the measured or estimated LA diameter was used. CONCLUSIONS: Substitution of measured LA diameter by estimated LA diameter in the HCM-SCD calculator did not reclassify risk.
No takes yet. Share an insight, caveat, or question.
Bhopalwala et al. (2020) conducted a cross-sectional in Hypertrophic cardiomyopathy (n=500). Estimated LA diameter derived from LAVI vs. Measured LA diameter was evaluated on Median sudden cardiac death risk at 5 years. Substitution of measured LA diameter with estimated LA diameter derived from LAVI maintained the same 5-year sudden cardiac death risk classification in 95% of patients.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: